BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 22, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company focused on cardiovascular disease, announced today that it will host a conference call with members of Amarin senior management to discuss the company's fourth quarter and year-end 2011 financial results and 2012 business initiatives on Wednesday, February 29, 2012, at 4:30 p.m. EST. The conference call will follow the anticipated release of the company's fourth quarter and year-end 2011 financial results earlier that day.
